Athersys Inc (ATHXQ)
0.0046
0.00 (0.00%)
USD |
OTCM |
May 17, 16:00
Athersys Cash from Financing (TTM): 11.63M for Sept. 30, 2023
Cash from Financing (TTM) Chart
Historical Cash from Financing (TTM) Data
Date | Value |
---|---|
September 30, 2023 | 11.63M |
June 30, 2023 | 19.65M |
March 31, 2023 | 26.04M |
December 31, 2022 | 30.84M |
September 30, 2022 | 32.64M |
June 30, 2022 | 34.75M |
March 31, 2022 | 38.27M |
December 31, 2021 | 63.41M |
September 30, 2021 | 63.67M |
June 30, 2021 | 51.47M |
March 31, 2021 | 99.26M |
December 31, 2020 | 79.48M |
September 30, 2020 | 76.83M |
June 30, 2020 | 80.41M |
March 31, 2020 | 24.45M |
December 31, 2019 | 19.89M |
September 30, 2019 | 22.20M |
June 30, 2019 | 20.47M |
March 31, 2019 | 15.22M |
December 31, 2018 | 36.01M |
September 30, 2018 | 36.15M |
June 30, 2018 | 39.90M |
March 31, 2018 | 42.49M |
December 31, 2017 | 38.87M |
September 30, 2017 | 33.12M |
Date | Value |
---|---|
June 30, 2017 | 28.10M |
March 31, 2017 | 26.17M |
December 31, 2016 | 3.724M |
September 30, 2016 | 2.016M |
June 30, 2016 | 0.444M |
March 31, 2016 | 2.722M |
December 31, 2015 | 10.80M |
September 30, 2015 | 10.83M |
June 30, 2015 | 10.88M |
March 31, 2015 | 8.132M |
December 31, 2014 | 20.27M |
September 30, 2014 | 39.05M |
June 30, 2014 | 43.80M |
March 31, 2014 | 48.02M |
December 31, 2013 | 29.58M |
September 30, 2013 | 32.20M |
June 30, 2013 | 28.23M |
March 31, 2013 | 24.17M |
December 31, 2012 | 30.52M |
September 30, 2012 | 9.963M |
June 30, 2012 | 9.233M |
March 31, 2012 | 9.084M |
December 31, 2011 | 12.60M |
September 30, 2011 | 11.84M |
June 30, 2011 | 11.84M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (TTM) Range, Past 5 Years
11.63M
Minimum
Sep 2023
99.26M
Maximum
Mar 2021
44.19M
Average
33.70M
Median
Cash from Financing (TTM) Benchmarks
Merck & Co Inc | -5.57B |
MEI Pharma Inc | -11.66M |
ContraFect Corp | 23.54M |
Bristol-Myers Squibb Co | 8.278B |
Predictive Technology Group Inc | 7.785M |